Strategies to Enhance Diagnostic Capabilities for the New Drug-Resistant Tuberculosis (DR-TB) Drugs

Strategies to Enhance Diagnostic Capabilities for the New Drug-Resistant Tuberculosis (DR-TB) Drugs

The global burden of drug-resistant tuberculosis (DR-TB) continues to challenge healthcare systems worldwide. There is a critical need to tackle DR-TB by enhancing diagnostics and drug susceptibility testing (DST) capabilities, particularly for emerging DR-TB drugs. This endeavor is crucial to optim...

Full description

Bibliographic Details
Main Authors: Antonia Morita Iswari Saktiawati, Anca Vasiliu, Francesca Saluzzo, Onno W. Akkerman
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Pathogens
Subjects:
diagnosis
drug resistance
tuberculosis
microbial sensitivity tests
antitubercular agents
global health
Online Access:https://www.mdpi.com/2076-0817/13/12/1045

Internet

https://www.mdpi.com/2076-0817/13/12/1045

Similar Items